relapsed and refractory solid tumors including metastatic colorectal cancer (mCRC), squamous cell or non-squamous non-small cell lung cancer, recurrent or metastatic squamous cell carcinoma of the ...

Envafolimab is under clinical development by Alphamab Oncology and currently in Phase I for Non-Small Cell Lung Cancer.